<SEC-DOCUMENT>0000950170-23-061558.txt : 20231109
<SEC-HEADER>0000950170-23-061558.hdr.sgml : 20231109
<ACCEPTANCE-DATETIME>20231109081603
ACCESSION NUMBER:		0000950170-23-061558
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20231109
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231109
DATE AS OF CHANGE:		20231109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Candel Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001841387
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				522214851
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40629
		FILM NUMBER:		231390186

	BUSINESS ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 450
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494
		BUSINESS PHONE:		617-916-5445

	MAIL ADDRESS:	
		STREET 1:		117 KENDRICK STREET
		STREET 2:		SUITE 450
		CITY:			NEEDHAM
		STATE:			MA
		ZIP:			02494

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Candel Therapeutics, Inic.
		DATE OF NAME CHANGE:	20210120
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>cadl-20231109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-11-09T07:39:09.0611+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:cadl="http://www.candeltx.com/20231109" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_6f4ba7c2-13c9-4044-9e81-450ae118018d" name="dei:EntityCentralIndexKey" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2">0001841387</ix:nonNumeric><ix:nonNumeric id="F_9ae41750-cb44-4764-8257-40ab0b04a20c" name="dei:AmendmentFlag" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" format="ixt:fixed-false">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="cadl-20231109.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001841387</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-09</xbrli:startDate><xbrli:endDate>2023-11-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double;padding-top:1pt;text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">SECURITIES AND EXCHANGE COMMISSION</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b1d8c76-935e-47aa-9d00-8f3bed627dda" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_515ef461-7976-4590-a038-e0fbe30acf34" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">November 9, 2023</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_302b2f5f-2bc2-4f67-ab37-886093df44ad" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">CANDEL THERAPEUTICS, INC.</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:9pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:33.333%;"></td>
    <td style="width:33.333%;"></td>
    <td style="width:33.333%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b876a9f3-dc67-47aa-8c58-db21b4cf85c4" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_802c36a0-97f0-4dbc-8a59-ae26d960845d" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">001-40629</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7011e4da-9101-4675-a799-fef2726805c0" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">52-2214851</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(State or Other Jurisdiction</span></p><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">of Incorporation)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(IRS Employer</span></p><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eb66fc36-a6fc-4657-90c6-81bb0b96ae30" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">117 Kendrick St</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">., </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5654517e-c17a-401b-86de-258da7a09d5c" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityAddressAddressLine2"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Suite 450</span></ix:nonNumeric></span></p><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_80b0f7b3-0cc3-4003-a0fe-7119c916fa74" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Needham</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">, </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b282b600-a617-4d0b-80b3-a564e2038431" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityAddressStateOrProvince"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">MA</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:bottom;"><p style="text-indent:0;font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:4pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f75d89b3-5110-4ced-a088-87d1f862142d" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">02494</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:8pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.1in;vertical-align:bottom;"><p style="text-indent:0;font-size:4pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:4pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code: </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d411c8fb-0607-4a67-bb96-b16c88f29e92" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(617)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3cbbff09-b5c3-43b4-863b-6d23bdc797d6" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">916-5445</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Not Applicable</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="margin-left:40%;text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:1pt solid;margin-right:40%;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:6pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4%;"></td>
    <td style="width:96%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_692c1c70-6de6-4d63-8a5b-1ff6b13d6457" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cb75ba76-dc7e-4f94-a527-e8d09504879f" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_efca5ff6-a792-4e69-adbb-a22bacf60d7f" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ea5ea731-ed99-4f65-8f14-fdc2bf65b99e" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;padding-left:0.01in;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:9pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:15%;"></td>
    <td style="width:1%;"></td>
    <td style="width:45%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Title of each class</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Trading</span></p><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Symbol(s)</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid #ffffff03;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:top;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b89d3587-ab9a-4b36-840f-7981445483d3" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Common Stock, $0.01 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_861190f3-18ee-492b-b2ee-06bfd38ba7f8" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">CADL</span></ix:nonNumeric></span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p></td>
    <td style="word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:left;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aa011151-d2ee-4e78-9031-a5951ed2a3fc" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Nasdaq Global Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x2009;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x2009;240.12b-2 of this chapter).</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:8pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5410f520-43d1-49bb-9827-46cc817306bd" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3699c6e7-1005-412e-b553-3e63a45bef8c" contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0;padding-bottom:1pt;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:2pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:18pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 2.02 Results of Operations and Financial Condition.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 9, 2023, Candel Therapeutics, Inc. announced its financial results for the quarter ended September 30, 2023. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The information in this Current Report on Form 8-K (including Exhibit 99.1 attached hereto) is furnished herewith and shall not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d) Exhibits</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:7.08%;"></td>
    <td style="width:2.02%;"></td>
    <td style="width:90.9%;"></td>
   </tr>
   <tr style="height:8pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Exhibit</span></p><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Number</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #ffffff03;padding-right:0.01in;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:8pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;text-align:left;"><p style="text-indent:0;font-size:8pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:8pt;font-family:Times New Roman;min-width:fit-content;">Description</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;99.1</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span><a href="cadl-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Press Release dated November 9, 2023</span></a></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;104</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.46%;"></td>
    <td style="width:5.04%;"></td>
    <td style="width:3.04%;"></td>
    <td style="width:46.46%;"></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td colspan="2" style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Candel Therapeutics, Inc.</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: November 9, 2023</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:top;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">By:</span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.25pt solid #000000;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">/s/ Paul Peter Tak</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:middle;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Paul Peter Tak, M.D., Ph.D., FMedSci</span></p></td>
   </tr>
   <tr style="height:10pt;">
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p></td>
    <td style="background-color:#ffffff;padding-top:0.01in;word-break:break-word;white-space:pre-wrap;vertical-align:bottom;padding-right:0.01in;"><p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>cadl-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:'Calibri',sans-serif;font-style:italic;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img160460863_0.jpg" alt="img160460863_0.jpg" style="width:222px;height:98px;">&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:14pt;font-family:Arial;min-width:fit-content;">Candel Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:14pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Initial survival data from phase 2 clinical trial of CAN-2409 in advanced non-small cell lung cancer (NSCLC) showed survival supportive of an increased tail on the maturing survival curve</font></div></div>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Initial data from phase 2 clinical trial of CAN-2409 in borderline resectable pancreatic cancer demonstrated an estimated survival rate of 71.4% at 36 months in patients treated with both CAN-2409 and standard of care (SoC) chemoradiation versus 16.7% in the control arm after standard of care (SoC) chemoradiation</font></div></div>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Data published in Nature demonstrated treatment with CAN-3110 nearly doubled expected median overall survival in patients with recurrent high-grade glioma (HGG); immunological changes in the tumor microenvironment and herpes simplex virus-1 seropositivity were associated with improved survival</font></div></div>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:11pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;font-style:italic;min-width:fit-content;">Significant discovery through the novel enLIGHTEN&#153;Discovery Platform demonstrated monotherapy activity of Alpha-201-macro1, the first experimental viral immunotherapy agent developed using the enLIGHTEN&#153; advanced analytics, in a preclinical model of breast cancer </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;"><br></font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">NEEDHAM, Mass., November 9, 2023 (GLOBE NEWSWIRE) &#x2014; </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Candel Therapeutics, Inc. (Candel or the Company)</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">(Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing viral immunotherapies to help patients fight cancer, today reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">&#x201c;Candel has made very significant progress with our viral immunotherapy platforms and oncology-focused pipeline,&#x201d; said Paul Peter Tak, MD, PhD, FMedSci, President and Chief Executive Officer of Candel. &#x201c;We are encouraged by the recent clinical and biomarker data for CAN-2409 in NSCLC and pancreatic cancer, and CAN-3110 in recurrent HGG. The quality of the science was recently validated by a publication in </font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;font-style:italic;min-width:fit-content;">Nature.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> Our off-the-shelf investigational medicines are designed to elicit individualized, systemic anti-tumor immune responses and, to date, have shown promise for extended survival beyond historical rates, along with a generally favorable safety and tolerability</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">profile. We observed markedly increased immune cell infiltration in immunosuppressive tumors and systemic immune activation after experimental treatment with both CAN-2409 and CAN-3110.&#x201d;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">&#x201c;We look forward to multiple anticipated data readouts in 2024, including topline overall survival data from the phase 2 clinical trial of CAN-2409 in NSCLC in Q2 2024, topline progression-free survival data from the randomized phase 2 study of CAN-2409 vs. active surveillance alone in early localized prostate cancer, and topline disease-free survival data from the randomized phase 3 clinical trial of CAN-2409 in intermediate to high risk localized prostate cancer in Q4 2024, in addition to the first data on multiple injections of CAN-3110 in recurrent HGG in the second half of 2024,&#x201d; Dr. Tak concluded.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Third Quarter 2023 &amp; Recent Highlights</font></p>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Program Updates:</font></div></div>
  <div style="margin-left:10%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;font-style:italic;min-width:fit-content;">CAN-2409 &#x2013; Non-Small Cell Lung Cancer (NSCLC)</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Initial data from the phase 2 NSCLC clinical trial suggested promising extension of overall survival, consistent with an increased tail on the maturing survival curve in patients whose disease progressed despite receiving anti-PD(L)1 treatment (Cohort 2).</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Data showed 93% of patients with long survival (&#x2265;12 months) were low or negative for PD-(L)1 expression, which supports the potential of CAN-2409 to convert patients unresponsive to immune checkpoint inhibitor treatment into long-term survivors.</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Robust activation of the immune system and immunological correlations between early changes in key effector immune populations after CAN-2409 treatment and survival suggested the potential to use early biological readouts as predictors of clinical response.</font></div></div>
  <div style="margin-left:10%;text-indent:0;display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:12pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;font-style:italic;min-width:fit-content;">CAN-3110 - Recurrent High-Grade Glioma (HGG)</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Nature published results from the phase 1 investigator-sponsored clinical trial of CAN-3110 in 41 patients with recurrent HGG.</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">New findings demonstrated that the proposed dual mechanism of CAN-3110 to trigger potent oncolysis and immune activation may be further enhanced in the presence of pre-existing antibodies to HSV (herpes simplex virus)-1.Median overall survival (mOS) of 14.2 months was observed in the patients with antibodies to HSV-1 virus (66%), present either at baseline or developed after CAN-3110 treatment.</font></div></div>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">As of the data cut-off of April 20, 2023, data support the continued tolerability of a single injection of CAN-3110 in recurrent HGG with no dose-limiting toxicity and observed nearly doubling of the expected mOS in 50 patients (Arm A and B). </font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">The observed increase in diversity of the T-cell receptor repertoire associated with improved survival after a single injection, suggests that CAN-3110 can induce a broad and diverse immune response against HSV-1 and against the newly released tumor antigens. </font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Arm C, supported by the Break Through Cancer Foundation, is currently evaluating the effects of repeat dosing of CAN-3110 (up to six injections over four months). </font></div></div>
  <div style="margin-left:10%;text-indent:0;display:flex;margin-top:8pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;font-style:italic;min-width:fit-content;">CAN-2409 &#x2013; Pancreatic Cancer</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Positive overall survival and immunological biomarker data were presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting for 2023, based on an interim analysis of the ongoing, randomized, phase 2 clinical trial of CAN-2409 plus prodrug together with SoC chemoradiation followed by resection for borderline resectable non-metastatic pancreatic ductal adenocarcinoma (PDAC) as of the August 21, 2023 data cutoff date.</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">An estimated survival rate of 71.4% at 36 months was observed in patients who received 2 or 3 injections of CAN-2409 regimen together with SoC chemoradiation prior to surgery, versus only 16.7% estimated survival at 36 months with SoC chemoradiation prior to surgery.</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Patients whose cancer progressed showed an altered disease course after salvage chemotherapy with improved CA19-9 levels (biomarker of tumor burden) and ongoing survival. Similar responses were not observed in the control arm.</font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Biomarker analysis demonstrated dense aggregates of immune cells that included CD8 positive granzyme B positive cytotoxic T cells, dendritic cells, and B cells in PDAC tissue resections obtained after CAN-2409 treatment, which confirmed activation of a robust antitumoral immune response.</font></div></div>
  <div style="margin-left:10%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:6pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.7033333333333336%;">o</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;font-style:italic;min-width:fit-content;">enLIGHTEN&#153; Discovery Platform </font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Presented the first experimental agent from the enLIGHTEN&#153; Discovery Platform, Alpha-201-macro1, during SITC. This new agent is an investigational viral immunotherapy that is designed to interfere with the CD47/ SIRP&#x3b1; pathway and activate innate immune surveillance. Results demonstrated monotherapy activity </font></div></div>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;visibility:hidden;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;"></font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">following local administration in a preclinical model of breast cancer.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></div></div>
  <div style="margin-left:16.667%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.999615998463994%;">&#x25aa;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Additional preclinical data presented at SITC confirmed the capability of the enLIGHTEN&#153; Advanced Analytics suite to predict optimal gene payload combinations to arm viral vectors, that enable the design of potential combination therapeutics to overcome tumor resistance especially in cancers resistant to immune checkpoint inhibitor treatment.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Anticipated Milestones</font></p>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:6pt;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Expect to report topline overall survival data on the phase 2 clinical trial of CAN-2409 plus valacyclovir combined with continued PD-(L)1 targeting agents in patients whose disease progresses despite receiving anti-PD-(L)1 treatment with late-stage NSCLC (Cohort 2) in Q2 2024.</font></div></div>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Expect to report topline disease-free survival data on the fully enrolled, pivotal, placebo-controlled, randomized phase 3 clinical trial of CAN-2409 in combination with valacyclovir in localized intermediate/high-risk prostate cancer in Q4 2024. </font></div></div>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Expect to report topline progression-free survival data on the fully enrolled, placebo-controlled, randomized phase 2 clinical trial of CAN-2409 in patients with low-to-intermediate-risk, localized, non-metastatic prostate cancer in Q4 2024. </font></div></div>
  <div style="margin-left:3.333%;text-indent:0;display:flex;margin-top:0;justify-content:flex-start;align-items:baseline;margin-bottom:8pt;min-width:3.333%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Times New Roman;min-width:fit-content;text-indent:0;display:inline-flex;font-size:12pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="width:100%;display:inline;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Expect to report clinical and immunological biomarker data in patients with recurrent HGG enrolled into Arm C, evaluating repeat dosing regimen of CAN-3110 in 2H 2024.</font></div></div>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Financial Results for the Quarter Ended September 30, 2023</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Research and Development Service Revenue, related party:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> Research and development service revenue, related party, was $0 for the third quarter of 2023 compared to $31,000 for the third quarter of 2022, as the amortizable $1.0 million up-front license fee that Candel received in 2014 and 2015 from Ventagen LLC was fully recognized as of December 2022.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:1.259%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Research and Development Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> Research and development expenses were $5.8 million for the third quarter of 2023 compared to $5.4 million for the third quarter of 2022. The increase was primarily due to manufacturing and regulatory activities in support of the Company&#x2019;s CAN-2409 programs. Research and development expenses included non-cash stock compensation expense of $0.3 million for both the third quarter of 2023 and the third quarter of 2022.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0.5pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.259%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">General and Administrative Expenses:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> General and administrative expenses were $3.0 million for the third quarter of 2023 compared to $3.5 million for the third quarter of 2022. The decrease was primarily due to lower professional service and consulting expenses, recruiting and insurance costs. General and administrative expenses</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:2.259%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">included non-cash stock compensation expense of $0.4 million for both the third quarter of 2023 and the third quarter of 2022.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0.95pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.009%;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Net Loss:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> Net loss for the third quarter of 2023 was $8.4 million compared to a net loss of $8.7 million for the third quarter of 2022, and included net other income of $0.4 million and $0.2 million, respectively, primarily related to the change in the fair value of the Company&#x2019;s warrant liability.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.009%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Cash Position:</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> Cash and cash equivalents as of September 30, 2023 were $43.0 million. The Company expects that its existing cash and cash equivalents will be sufficient to fund its current operating plan into the second quarter of 2024.</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.009%;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Candel Therapeutics, Inc.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Condensed Consolidated Statements of Operations</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;min-width:fit-content;">(in thousands, except share and per share amounts)</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;min-width:fit-content;">(Unaudited)</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img160460863_1.jpg" alt="img160460863_1.jpg" style="width:624px;height:287px;">&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Candel Therapeutics, Inc.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Consolidated Balance Sheet Data</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:11pt;font-family:Arial;min-width:fit-content;">(in thousands)</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:1.6pt;font-family:Times New Roman;margin-bottom:0;margin-right:1.009%;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><img src="img160460863_2.jpg" alt="img160460863_2.jpg" style="width:624px;height:222px;">&#160;</p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">About Candel Therapeutics</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Candel is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel&#x2019;s engineered viruses are designed to induce immunogenic cell death through direct viral-mediated cytotoxicity in cancer cells, thus releasing tumor neo-antigens while creating a pro-inflammatory microenvironment at the site of injection. This leads to in situ vaccination against the injected tumor and uninjected distant metastases.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Candel has established two clinical stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. CAN-2409 is the lead product candidate from the adenovirus platform and is currently in ongoing clinical trials in NSCLC (phase 2), pancreatic cancer (phase 2), and localized, non-metastatic prostate cancer (phase 2 and phase 3). CAN-3110 is the lead product candidate from the HSV platform and is currently in an ongoing investigator-sponsored phase 1 clinical trial in recurrent high-grade glioma. In addition, Candel&#x2019;s enLIGHTEN&#153; Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">For more information about Candel, visit: </font><font><font style="white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">www.candeltx.com</font></font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Forward-Looking Statements</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> This press release includes certain disclosures that contain &#x201c;forward-looking statements,&#x201d; within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including, without limitation, express or implied statements regarding the timing and advancement of development programs, including the timing and availability of additional data, key data readout milestones and presentations, the possibility to use early biological readouts as predictor of clinical response and, expectations regarding the therapeutic benefit of its programs, including the potential for CAN-2409its programs to extend patient survival, and expectations regarding cash runway and expenditures. The words &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;could,&#x201d; &#x201c;would,&#x201d; &#x201c;should,&#x201d; &#x201c;expect,&#x201d; &#x201c;plan,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;intend,&#x201d; &#x201c;believe,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;project,&#x201d; &#x201c;potential,&#x201d; &#x201c;continue,&#x201d; &#x201c;target&#x201d; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Any forward-looking statements in this press release are based on management&#x2019;s current expectations and beliefs and are subject to a number of risks, uncertainties and important factors that may cause actual events or results to differ materially from those expressed or implied by any forward-looking statements contained in this press release, including, without limitation, those risks and uncertainties related to the timing and advancement of development programs; the timing of data readout milestones and presentations; that final data from our pre-clinical studies and completed clinical trials may differ materially from reported interim data from ongoing studies and trials; expectations regarding the therapeutic benefit of the Company&#x2019;s programs; the Company&#x2019;s ability to efficiently discover and develop product candidates; the Company&#x2019;s ability to obtain and maintain regulatory approval of product candidates; the Company&#x2019;s ability to maintain its intellectual property; the implementation of the Company&#x2019;s business model; the</font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="white-space:pre-wrap;font-size:11pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Company&#x2019;s ability to raise additional capital; the Company&#x2019;s ability to continue as a going concern; and strategic plans for the Company&#x2019;s business and product candidates, and other risks identified in the Company&#x2019;s SEC filings, including the Company&#x2019;s most recent Quarterly Report on Form 10-Q filed with the SEC, and subsequent filings with the SEC. The Company cautions you not to place undue reliance on any forward-looking statements, which speak only as of the date they are made. The Company disclaims any obligation to publicly update or revise any such statements to reflect any change in expectations or in events, conditions, or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements. Any forward-looking statements contained in this press release represent the Company&#x2019;s views only as of the date hereof and should not be relied upon as representing its views as of any subsequent date.</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Media Contact<br></font><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Aljanae Reynolds<br>Director<br>Wheelhouse Life Science Advisors<br></font><font style="color:#ed7d31;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">areynolds@wheelhouselsa.com</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Arial;min-width:fit-content;">Investor Contact</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Sylvia Wheeler</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Principal</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">Wheelhouse Life Science Advisors</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#ed7d31;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;">swheeler@wheelhouselsa.com</font><font style="color:#ed7d31;white-space:pre-wrap;font-weight:normal;font-size:12pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:11pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:0;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:8pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img160460863_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img160460863_0.jpg
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M0R!S4D="                  #VU@ !     -,M2% @(
M                                                $6-P<G0   %0
M    ,V1E<V,   &$    ;'=T<'0   'P    %&)K<'0   ($    %')865H
M  (8    %&=865H   (L    %&)865H   )     %&1M;F0   )4    <&1M
M9&0   +$    B'9U960   -,    AG9I97<   /4    )&QU;6D   /X
M%&UE87,   0,    )'1E8V@   0P    #')44D,   0\   (#&=44D,   0\
M   (#&)44D,   0\   (#'1E>'0     0V]P>7)I9VAT("AC*2 Q.3DX($AE
M=VQE='0M4&%C:V%R9"!#;VUP86YY  !D97-C         !)S4D="($E%0S8Q
M.38V+3(N,0              $G-21T(@245#-C$Y-C8M,BXQ
M                                                      !865H@
M        \U$  0    $6S%A96B                      6%E:(
M &^B   X]0   Y!865H@        8ID  +>%   8VEA96B         DH
M#X0  +;/9&5S8P         6245#(&AT=' Z+R]W=W<N:65C+F-H
M       6245#(&AT=' Z+R]W=W<N:65C+F-H
M                                     &1E<V,         +DE%0R V
M,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'0@
M        +DE%0R V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E
M("T@<U)'0@                            !D97-C         "Q2969E
M<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M       L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V
M+3(N,0                                  =FEE=P      $Z3^ !1?
M+@ 0SQ0  ^W,  03"P #7)X    !6%E:(       3 E6 %    !7'^=M96%S
M          $                        "CP    )S:6<@     $-25"!C
M=7)V        !      %  H #P 4 !D '@ C "@ +0 R #< .P!  $4 2@!/
M %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\ I "I *X L@"W +P
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MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@ , P$
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M97;.TD'.&QV.*X+P;\-?"7PU^)S7#^(@^KWA<VUC.ZJP#GGW/?%>G^/-8O\
M1?">I7^DV_VR_A@9X80"<L!Z#K7-AXQCAYPG&R5U9/I_F=&(DY8B-2$FV[.[
M5M?\C ^"_P -)_A?X8>PNKM;NXDE,K>6"$7/9<UN?$9=*F\(ZC'K5VMEILD1
M2:8MC:#6!\#_ !7XC\8>%Y;SQ'9?9+@2E8V\LQ^8OKM/2K?QBL_#VI>#I[3Q
M)J*Z9I\KJ!-OVD-GC'K6T7%87W596T3_ %,?>>*]^5W?5K7[CC_V??ASX?\
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MXBT&_P!-DD:$74+PF1#RNX8R/SKR_P"#?P./PKU"_P!1N=3%[++'Y*!4V*J
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M^==I;0QPQJ(D6->NU1@=>:THQCS-1>BW7FR*DI<JE-:O9^2)(XUBC54&U5X
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MD_#73YMMYK3"\O\ 8>5MD/R*?]YP3]$KPG_@F#\<#X!^+ESX+U"XV:1XH3$
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MF_I7X8Z;_P A*T_Z[+_.O8P7\.1Q5OCB?T6:*Q;1[!F.6,$9/_?(J]5+0_\
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M3M#)! QPOE!U*EN.K8_G7MK8[G%-^]WXKSYX&A.2DXJZV.R..Q$(N"D[2W/
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MW%OIVGPB)!@9<_Q.WJQ/)^M==117A-W=V>DMM HHHI %%%% !1110 5\9?\
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M/.ZY6=C1117E'4%?C?\ \%/?^3IKK_L#V?\ Z"U?LA7XW_\ !3W_ ).FNO\
ML#V?_H+5Z.!_C'/B/@*?[(O[+=A^TU\,?B;;)+]C\3Z1)9SZ3=9^7>R3[H7'
M]Q]JY/4$ UX R^*/@O\ $$C-UX>\5Z#=\$?+)#*IZ^X/Y$'TK[__ ."/?_'I
M\4O^NNG?^@W%>H?M\?L;Q_&[09/%WA6T1/'&FQ9DC0;?[0@7DH?]L?PGOR*[
M7B>6O*G/9G-[/FIJ4=SL_P!B_P#:\TW]I+PG]EU!H;#QKIZ 7UBAPLR\ 31
M\[3W'8YKZ86OYYO /CSQ'\'?'5EXAT*YFTK7=+F. P(Y'#QR+W!Y4J:_:_\
M9=_:6T/]I3P#%K.GE;75K8+%J>FLWSV\V.2/5#S@UPXK#>S?/#8Z*-3F7*]Q
M/VUO^35/B=_V!IOZ5^&.F_\ (2M/^NR_SK]SOVUO^35/B=_V!IOZ5^&.F_\
M(2M/^NR_SKJP/\*1EB/CB?T5Z)_R!=/_ .N$?_H(J_5#1/\ D"Z?_P!<(_\
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M.[[6,#S=PQL]L9_2MKXT>&_'NM>*-%?PQ>M#I\?^L"/MVR9^\WJ,=O8U[/A
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M<\$?"_QII/Q;OM<OM2W:3)),W^N+&5&^XNWH,<?E7N4=C;V\C2K%&DK?>?:
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MJPZ,#Z&OT.^$'_!6#1[NUAM/B+X?N+"[48;4-('F1.?4QL05_ GZ5I?M"?\
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M&%51@*!V K'$8Q<OLZ1=.B[\TR95"X &T"EHHKR3L"OFC_@HK_R:CXL^MO\
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M>#2M6!J>%_$3]L[X3?"OQ9=^&_$?B4V6L6H0S0+:2OLW*&7E5(Z$?G4?@?\
M;:^#/Q"UJWT?2O&EJ-0N'$<,-W%);^8Q[!G4+GVSWKXS\3^ = ^)G_!32_\
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MK8Q.WF$G:,L 0,G Y]:[3PS_ ,BWI/\ UZ0_^@"OS_\ VX?^3SO@G_U]0?\
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MZ$GI6%.I['%2IRE\2NE;;YFM2G[;"QJ1C\+LW?5_(]<HHHKVSR K\\?VR/\
MD_KX'_\ 72S_ /2EJ_0ZOB[]IKX$^-_''[87PF\7Z)HC7OAW27M_MUZL\:B
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M4H3BFY+1M[6/H&BHHVW*ISR1V_S]:EKZ"+YE<\(****8!1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %"]#1142!!1115@%%
M%% !1110 4444( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img160460863_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img160460863_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &( U0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BJ&L'4%TZ1],N+6"X0%]US;M,I
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M/!9,A\R5 [0I$I;H3Q(,\C SFK=]J7B>/PIXFU*/6-6@@TU6ETZYNK&&&6Y
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MF.3X=Z*FJ6.I![O[5975S<QOO7DSDEU/R\J">.X]35>+X9Z8NE?V=<:GJEW
MEC)86WG-$#;128W;-L8RQP.6W=/K6?X7\5ZOJ/B+3_M5PTEKJHOR+9HD M?L
M\P1-I #'(SNW$\],=*]%H7PJW]=!M^\^YS%SX->[MK..X\1ZO)-97 N+:XVV
MP>-@C)C AVD88]03[UK:+HUMH6G_ &2V>63=(\TLTQ!>61V+,[$ #))[ #T
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MUK8HH Y__A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ !FN@HH Y_\
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MVR+]Y>0,XSU'%'LV/VT3>HK.^U3?W_T%'VJ;^_\ H*/9L7MHFC16=]JF_O\
MZ"J6G^((-4:[6RNO--G<-;3_ +LKLD4 E>0,]1R.*/9L?MHF]16#J/B"#25M
MFOKKRA<W"6T7[LMND<X5> <9]3Q5W[5-_?\ T%'LV'MHFC16=]JF_O\ Z"C[
M5-_?_04>S8O;1-&BL'2M?@UO3TO].N?.MG9E5_+*Y*L5/# 'J#5W[5-_?_04
M>S8_;1-&BL[[5-_?_04?:IO[_P"@H]FQ>VB:-%9WVJ;^_P#H*/M4W]_]!1[-
MA[:)HT5EQW[3('BG5T.0&7!'!P?UI_VJ;^_^@H]FP]M$T:*SOM4W]_\ 04?:
MIO[_ .@H]FP]M$T:*P;?Q!!=:I>:;#=;KNS"-/'Y9&P."5Y(P<@'H35W[5-_
M?_04>S8_;1-&BL[[5-_?_04?:IO[_P"@H]FQ>VB:-%9WVJ;^_P#H*/M4W]_]
M!1[-A[:)HT5G?:IO[_Z"C[5-_?\ T%'LV'MHFC16=]JF_O\ Z"C[5-_?_04>
MS8>VB:-%9WVJ;^_^@H^U3?W_ -!1[-A[:)HT5@V_B""ZU2\TV&ZW7=F$:>/R
MR-@<$KR1@Y /0FK4M^T,;22SK'&O+,^ !^-'LV/VT34HK.^U3?W_ -!5/5=?
M@T33)M1U&Y\FT@ ,DGEEMH) Z*">I%'LV"K)Z)&[16:+N4@$/P?84OVJ;^_^
M@H]DQ>WB:-%9WVJ;^_\ H*9]O;SA#YZ^:5W;.,XZ9QZ4>S8>VB:E%9WVJ;^_
M^@H^U3?W_P!!1[-A[:)HT5G?:IO[_P"@H^U3?W_T%'LV'MHFC16=]JF_O_H*
M/M4W]_\ 04>S8>VB:-%9WVJ;^_\ H*/M4W]_]!1[-A[:)HT5S%Y9:I=7;S0^
M)=3M(VQB""*U*+QC@O"S<]>2>OX5!_96L?\ 0XZU_P!^;+_Y'I>SD/VT3KJ*
MY'^RM8_Z''6O^_-E_P#(]']E:Q_T..M?]^;+_P"1Z/9R#VT2OXG\.Z]KGBW3
M+@I87/A^QVS"REO)(6>X#9$C@1,&"CHN1SU-9]CX'US2;H2V,^G9TZ*^&EM(
M[DN]Q)O!E&WY0G3@MN]JV/[*UC_H<=:_[\V7_P CT?V5K'_0XZU_WYLO_D>C
MV<K??^(_;1_+\#+T3PKXATCPQ-8O9:)>WMW,TFI->W<LPO\ <N&8MY0V<XPN
MUQM&,@\UU_AW3;G1_#NGZ=>7C7EQ;PK').V?G([\\_G6)_96L?\ 0XZU_P!^
M;+_Y'H_LK6/^AQUK_OS9?_(]/DD+VL3KJ*Y'^RM8_P"AQUK_ +\V7_R/1_96
ML?\ 0XZU_P!^;+_Y'I>SD'MHG745R/\ 96L?]#CK7_?FR_\ D>M:S:[M;1(9
MKZ:[D7.9YUC#MSGD(JKQTX Z?C3]FP]M$V**Q[QKNZM'AAOIK21L8G@6,NO.
M> ZLO/3D'K^-9/\ 96L?]#CK7_?FR_\ D>CV;#VT3KJ*Y'^RM8_Z''6O^_-E
M_P#(]']E:Q_T..M?]^;+_P"1Z7LY![:)T>J#4&TJZ72C NH&)A;M<$B,/C@M
M@$XS[5YYIG@'6["QT^[9-/DUVTO)+J:>6_DD6^:6)HW9V\H&/&1M 5@ N.^:
MZ#^RM8_Z''6O^_-E_P#(]']E:Q_T..M?]^;+_P"1Z/9/4?MHF O@/7H)?#6G
MLVGWV@Z-#&QMGNY(#-<@Y\U@(W#*O55R.>IK7T'P[KT/CC4-?UY+"Y:7=#9R
MQ7DA-K;Y!6-8C$!DD99MWX>MC^RM8_Z''6O^_-E_\CT?V5K'_0XZU_WYLO\
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M!,^IS!WG#L< E\L!UV\@=<"O7OLLW]S]145Q87,]M)%'));NZD"6+860^HW
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M=M<37]GJ.G"*R.H(MS$N9X!P638S#J1\IPPR,BLR;X66M]K.HWU_?(Z7D%Q
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC-+'+,S)N3R0FU2<)@.1\H&>IR>:44GT_JS?Z W)+<]'^U3?W_T%'VJ;^_\
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M .@H^U3?W_T%0T4<J[!SR[DWVJ;^_P#H*/M4W]_]!4-%'*NP<\NY-]JF_O\
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M-JS7.H6HDU"RFM&EL]/6W:7S#GS9\,1+(,<$!!RW'S<=))?M$%,DZH&8*N[
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M_P#04?:IO[_Z"CV;#VT31HK.^U3?W_T%'VJ;^_\ H*/9L/;1-&BL[[5-_?\
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MJ,KLJC"C>Z%@%[ $8/(P:MZ=J.B:5;2P6FG>( LSF25I=(OY7D8@#+.\98G
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MDC,>Q&.3DJ ?F/J<M-7O<&G:UNG^?^9V]E_KC_NU>KG-(U^TO-02VCMM51Y
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MJAU"ZMX5,=KN 8;LL&;@Y(0-@=<5GZS\.YM4'B2./5XX(->C@$JFT+M')&%
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MGW_7_+^F)VZ=OT7]?H=&GB>.;Q?_ &!#97!Q;2S-=2(T<99&12B9'S_?&6'
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M]!7CG]L6;IX%!\1:HNEW,-W]NGFO9(W=U1<B5@V5PV>_R]CBJO\ ;6N?V=H
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MK7_?FR_^1ZUZ*.2/8/:2[F1_96L?]#CK7_?FR_\ D>C^RM8_Z''6O^_-E_\
M(]:]%')'L'M)=S$BT34X=_E>+-7C\QB[[;>R&YCU)_T?D^]2?V5K'_0XZU_W
MYLO_ )'K7HHY(]@]I+N9']E:Q_T..M?]^;+_ .1Z/[*UC_H<=:_[\V7_ ,CU
MKT4<D>P>TEW,0Z)J9G6<^+-7,RJ460V]EN"D@D _9\X.!Q["MJS:[M;1(9KZ
M:[D7.9YUC#MSGD(JKQTX Z?C2T4<J["YY=Q+QKNZM'AAOIK21L8G@6,NO.>
MZLO/3D'K^-9/]E:Q_P!#CK7_ 'YLO_D>M>BCE78.>7<R/[*UC_H<=:_[\V7_
M ,CT?V5K'_0XZU_WYLO_ )'K7HHY(]A^TEW,C^RM8_Z''6O^_-E_\CT?V5K'
M_0XZU_WYLO\ Y'K7HHY(]@]I+N8DNB:G/L\WQ9J\FQ@Z[[>R.UAT(_T?@CUJ
M3^RM8_Z''6O^_-E_\CUKT4<D>P>TEW,C^RM8_P"AQUK_ +\V7_R/1_96L?\
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M_P!!1]JF_O\ Z"CV;#VT31HK.^U3?W_T%'VJ;^_^@H]FP]M$T:*SOM4W]_\
M04?:IO[_ .@H]FP]M$T:*SOM4W]_]!1]JF_O_H*/9L/;1-&BL[[5-_?_ $%'
MVJ;^_P#H*/9L/;1-&N%>V\2:5X8%CI^G7+3W.I733RVLD'FP0/-(X=/,=5+D
M,N,D[<Y(.,'J?M4W]_\ 04?:IO[_ .@H]DQ^WB-\/P1VVBV]O%IEQIR1@J+>
MY='DZ\LS([@DG))W$DDD\UIUG?:IO[_Z"C[5-_?_ $%-TY,2K11HT5G?:IO[
M_P"@H^U3?W_T%+V;#VT31HK.^U3?W_T%'VJ;^_\ H*/9L/;1-&BL[[5-_?\
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M[5-_?_04*FT'MHFC152UFDDE(=LC&>E6ZAJSL:1DI*Z"BBBD4%%%% &==?\
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M;1N'7.,X.:;LNG]:?YDKF?7^K7^\]<-W, 3OZ>BTR&_DN((YD9PLBA@)(RC
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M2V(W1*6SG&Y]O/41,*JRTT_K1_K<B\K7OT_S_P OQ.X^U3?W_P!!1]JF_O\
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M\;'H>Q%+VK0_8IZ7-_[+-_<_44?99O[GZBLJXUM?#1LM,GGU37=3O2[P1+'
M)650"Q) CC51D<G!.<<UFK\14O?$&@6&F:9<7-OJ1G69V*));M$<.A5F'*GE
MO;[N[-/VC%[&-KG3_99O[GZBC[+-_<_45B6/Q TN]\1P:&UM>VMW<B0V_P!I
M5%,FP9.4#F1.,D;U7.*7X>:U>ZWX(MM2U2X$UPTMP'E*JGRK*ZCA0!P */:N
MUQ^PB;7V6;^Y^HH^RS?W/U%8-I\1-,O?LKQ6&HK;7V]=/NI8T2.\=03M3+94
MG:<;PH..*YFR^(VM:I<>#;R/2[J*'5/MOG6,'DN;@1J-A1F;Y0"3]XID@\8Q
MD]H_Z_KR#V$3T3[+-_<_44?99O[GZBL.'XA:7>:?I5Q86=_>7&J"1K>RA1!,
M!&<2;MSA%VG@Y;GMFAOB%ICC1A966HWTVK><MO##&BNK1?ZQ7\QU"D'(ZXX/
M/3+]I+87L8FY]EF_N?J*/LLW]S]16;XOU:72K?2'CO9[0W.J6]LQBMTF,@=L
M%#N(V@]V&2.P-4D^(NF/?_9S8:DD(U5M(:Z9(_*6X' 'W]V#V(7ZXI*HWM_6
MW^:!T8K7^NO^3-_[+-_<_44?99O[GZBLVU\96E[J36]OIVI2VBW$EJVHI"&M
MUE3.X$AMX ((W%0N>]5M/^(.E:A-9%;6_@M-09TL;V>)5BNF4$D+\VX$A3C>
MJYQQFCVKM<?L(FW]EF_N?J*/LLW]S]17+V?Q/T^_&EFUT36I#JL<CV(\J(><
M8SAUYD^4CKEL+CH:N0_$+2[RPTN>PL]0O+G4Q*8+*&-!-B(XD+;F" *>,[N>
MV:?M)"]C$W/LLW]S]11]EF_N?J*;I6O6.L:&NKVCO]F*N6$B%60J2&5@>A!!
M!^E<KX?\=2R>'=(N+ZWN]0U36C/<6ME:1QAU@#DCEF50%4KRQR<]Z7M'>P>Q
MB=9]EF_N?J*/LLW]S]16%<_$?0K/2]-U2X^U1Z;?2/";MHL);2+G*2@G<IRK
M+P",C\:#X_M?*T,KHNKM/K:2R6=MY<0D*H V6S( N001D_7%'M&'L8F[]EF_
MN?J*/LLW]S]16'%\0M,NK73VLK+4;N]OFE6.PCC19T,1Q('WL$7:>#\W/;-!
M^(.ER#1Q96>H7LNK"<6\,,:*ZO#]]'WLH5@<CDXR.O2CVC#V$3<^RS?W/U%9
M]CH#65]>7K2SW%S=%=TDQ3*(N=L:[0!M&YNN3R<DUDM\4=$-GI4]O::E=2:E
M'))%;0Q*95$;;7RI898'(VIN8X. :NZAX^TO3[N]B:UU":WT_P O[?=Q0CR[
M3> 1O!8.>""=JMCOBCVDKC]C'8V?LLW]S]11]EF_N?J*R-%UNZE\;Z]HEU,)
MHHHX+RS;:!B*1<%>.H#*3D\_-6GXD\06GA?0;G6+V.>2WM]F]8%#.=S!1@$C
MNP[T>U>@O8Q;LB3[+-_<_44?99O[GZBL5OB!I4$6KM?6U]92Z6T2S031JSOY
MO^JV;&8'<3@<@COBL[7OB0-,T+4;F#1KQ=3L9(%EL;O8C(LK81\JY5E/(^5B
M<\'')![20>QB=7]EF_N?J*/LLW]S]15VWD>:WCED@D@=U#-%(5+(3V.TD9'L
M2/>I*/:,/8Q,[[+-_<_44?99O[GZBM&BCVC#V,3.^RS?W/U%'V6;^Y^HK1HH
M]HP]C$SOLLW]S]11]EF_N?J*T:*/:,/8Q,[[+-_<_44?99O[GZBM&BCVC#V,
M3.^RS?W/U%'V6;^Y^HK1HH]HP]C$SOLLW]S]11]EF_N?J*T:*/:,/8Q,[[+-
M_<_44?99O[GZBM&BCVC#V,3.^RS?W/U%'V6;^Y^HK1HH]HP]C$SOLLW]S]11
M]EF_N?J*T:*/:,/8Q.6OM<MM/O)+6:TU5Y$QDP:5<S(<@'ATC*GKV/'3K5?_
M (2BQ_Y\M<_\$=[_ /&J[&BCVC#V,3CO^$HL?^?+7/\ P1WO_P :H_X2BQ_Y
M\M<_\$=[_P#&J[&BCVC#V,3CO^$HL?\ GRUS_P $=[_\:H_X2BQ_Y\M<_P#!
M'>__ !JNQHH]HP]C$X[_ (2BQ_Y\M<_\$=[_ /&JANM>TJ^M)K6ZTW6IK>9"
MDD;Z%>$,IZ@_NJ[>BCVC'[&*/-XV\.)87-DVF>(IHKD 2M<:9J,TA ^Z!(Z%
MA@\C!&"21@U9T[4-$TJUDM[33=?5)7,DK2:/?R/(QX)9VC+,< #)/0 =JU[3
MQ@=2L=6N-.TN>Y:SO5L[=%)'V@LJ$2$X^2/]YG=S\HW<YQ47_"8WBB6QDTF+
M^VTODLEM8[S="S-'YH;S=@(41Y)^3.1@ Y!)[1OI_6G^:#V*[E2RUS2M/L8+
M*UT[7([>WC6*)/[$O3M51@#)BR>/6M^Q<ZA9QW4,4Z1OG GA>%Q@D<HX##IW
M'/7I5[39[RYL4DO[(6=SEE>%9A*HP2 58 9!'(R >>0#Q5NAU9"]C$QKYSI]
MG)=313O&F,B"%YG.2!PB L>O8<=>E8__  E%C_SY:Y_X([W_ .-5V-%'M&'L
M8G'?\)18_P#/EKG_ (([W_XU1_PE%C_SY:Y_X([W_P"-5V-%'M&'L8G'?\)1
M8_\ /EKG_@CO?_C5'_"46/\ SY:Y_P"".]_^-5V-%'M&'L8G'?\ "46/_/EK
MG_@CO?\ XU1_PE%C_P ^6N?^".]_^-5V-%'M&'L8GG5]-X>U&]%W<Z7X@,Q4
M(_EZ5J$:RJ"2%D58PLBC)X8$<GU-%U/X>O-2COY]*U]IT9'P-(U!49DY5F01
M[7*]BP)&!CI73^(?$\>@RV,(LKFZFNKF&']VC".)9) F]WQM&">%ZD].,D5K
MGQ;+;ZO=1?V<ITRSNH;.YNS/AQ+*$V[8]IW*/,C!)8'DX!Q0JC=K+K^/],;H
MKN8-O/X>M=4;48M*U\7+,[#.DZ@R(S_>9$,>U"W<J 3DYZFNBTC7[2\U!+:.
MVU5'D!"M/I5U"G SR[QA1T[GGIU-.;7]1M]>M+*^TB."TO9WM[:5;L/,2JLV
MYHPN%0A3R'8C*Y R<=#2<VU8:I)2OU"N:U77K6RU*:WDM=5=TQEH-*N9D.0#
MPZ1E3U['VZUTM%*,N75%2BI*S.._X2BQ_P"?+7/_  1WO_QJC_A*+'_GRUS_
M ,$=[_\ &J[&BJ]HS/V,3CO^$HL?^?+7/_!'>_\ QJC_ (2BQ_Y\M<_\$=[_
M /&J[&BCVC#V,3CO^$HL?^?+7/\ P1WO_P :JO?:WI.HV,]E=Z=KDEO<1F.5
M/[$OAN4C!&1%D?A7<UA^*_$L?A;1)]0:SN;R1(V=(($8[MHR2S $(H')8_AD
MX!/:,:H*^A@C7K,:@+D0>( @A\KR?[$OMN<YW8\O&>W3/OZ+;:UI-I-=2P:=
MKB/=2^;,?[$OCN?:JYYBXX51QZ5U][>?8],GO1;S7!BB,@A@3?)(0,[5'<GI
M7/+XJU2*6[L;O0!_:L<,,T-O:71F2197*#<^Q2FU@=QVD #()Z4>T=[?UW$J
M,;7Z&++-X>FL!9'2_$"0K.URABTK4(W21F9F976,,I)9NA'!(Z<5<LM;TG3K
M**TM--UN*")=J(-#O3C\3%DGN2>2:M'QC?*[:>='A_ML7RV0MUO<P$F+SM_F
M[-P78#_!G/&,<UOZ+JJZQIPN?*,,J22031;MVR1&*. >XW*<'N,<#I0JCZ#=
M%=?Z_K4K6+G4+..ZABG2-\X$\+PN,$CE' 8=.XYZ]*+YSI]G)=313O&F,B"%
MYG.2!PB L>O8<=>E;-%'M&+V,3CO^$HL?^?+7/\ P1WO_P :H_X2BQ_Y\M<_
M\$=[_P#&J[&BCVC#V,3CO^$HL?\ GRUS_P $=[_\:H_X2BQ_Y\M<_P#!'>__
M !JNQHH]HP]C$X[_ (2BQ_Y\M<_\$=[_ /&JK2:SH\U]'>R:;KC7$<3PJQT2
M]P$<J6&/*P<E5_*NZK 7Q1%)XN_L&.RNB%M99WNGC94+(R*43(^?[_)' X')
MS@]HQ^Q1RMF^@:;',+'3_$43/$84+Z7J,@A4_P ,89/W:].$VC@>@P7K^']3
MA@34-.\0W#11")G_ +)U!#,O&5DVQC>I(SM;(Y/'-=)I?B6_N=6L[/4M&^P+
M?P27%IFXWR;4*Y65"J^6V'4X!8=03ZFM^*I]+U&Z@M]-6YM["T6]OYFN/+,<
M1+ >6NT[VQ&YP2HX'.31[1_UY7^[J'L5W_K0YG;X=&HS7Z67BN*>:432^5::
MK&CL  "450IX &,8P,5,L_AY-7&J+I6O_:@Q=?\ B4Z@8U<C:7$?E[ Q&06
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MM4AR5_U> BJ3G;@DX&22,UF7WAOQ#9^(/ UO'J4E[-IZ7J-J<EDSHJF-0@F
M;DD#&=REB,]:[S[5-_?_ $%'VJ;^_P#H*/9N]P]M$XR7X46;6VF/]IM+G4+2
M2>6:34-/6X@N6F;<Y:'<,8;[N&X]ZT['P''8WWARYCO(5_L<7)9(;*.%9VF
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MVBC8HK'O&N[JT>&&^FM)&QB>!8RZ\YX#JR\].0>OXUD_V5K'_0XZU_WYLO\
MY'H]FP]M$ZZBN1_LK6/^AQUK_OS9?_(]']E:Q_T..M?]^;+_ .1Z7LY![:)U
MU%<C_96L?]#CK7_?FR_^1Z/[*UC_ *''6O\ OS9?_(]'LY![:)UU%<C_ &5K
M'_0XZU_WYLO_ )'H_LK6/^AQUK_OS9?_ "/1[.0>VB:GBBPN=1TNWAM(O,D2
M_M)F&X#").CL>3V52:P/$7AR35]>\N/0Y4$MS;2R:BMX/(9(V5B7AW#,OR[
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MN3_.JLK_ '_K_P #[R=;?=^G_!^XV=<\5Z+X<>)-5O?(:56=56)Y"$7&YVV
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M/_R#1_PL;6?^A8_\=U'_ .0:ZZBCV:#VS./?XAZO(C(_A8,C AE*:B01Z?\
M'A5?3_'.K:;I\%E'X<EDC@01HTHU%FVCH"?L'.!QGKQS7<44>S0>V9R/_"QM
M9_Z%C_QW4?\ Y!H_X6-K/_0L?^.ZC_\ (-==11[-![9G"S^-=3N=2M+Z7PR[
M/:!_*3;J&T,P +?\>&=V,@<]&/K7H-CJ@NM/MKB6%HI)8E=X\-\A(!(^8*W'
MNJGU Z5!11[-"]M(GOM4%KI]S<10M+)%$SI'AOG(!('RAFY]E8^@/2N*_P"%
MC:S_ -"Q_P".ZC_\@UUU%'LT'MI''+\0M61G9/"BJSG<Y$>H@L< 9/\ H'/
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MC@GIQSTIFE>#+;3-875'U+4;ZY6S^Q9NGC*F+((!"HHXQUZG)SFNDHH>KO\
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M3!X.U2S<\<9/&:RM+UW4;[3=6ATNZM]4FLYQ';WUPP1)$:-7$A\M=KX+$?*
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MR*/:H/8/N9=%:GE1_P#/-/\ OD4>5'_SS3_OD4>U0>P?<RZ*U/*C_P">:?\
M?(H\J/\ YYI_WR*/:H/8/N9=%:GE1_\ /-/^^11Y4?\ SS3_ +Y%'M4'L'W,
MNBM3RH_^>:?]\BCRH_\ GFG_ 'R*/:H/8/N9=%:GE1_\\T_[Y%'E1_\ /-/^
M^11[5![!]S+HK4\J/_GFG_?(H\J/_GFG_?(H]J@]@^YET5J>5'_SS3_OD4>5
M'_SS3_OD4>U0>P?<RZ*U/*C_ .>:?]\BCRH_^>:?]\BCVJ#V#[F716IY4?\
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MF.!DX&!DUH5RW_"H]#_Y^/\ RD:9_P#(M=M8Z?!8:?;6<:JR6\2Q*?+1<A0
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MQ7;YDCL7=L<X!9C@9.!@9-8W_"H]#_Y^/_*1IG_R+1_PJ/0_^?C_ ,I&F?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img160460863_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img160460863_2.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #Q J8# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?\1=7-M=W4%O>7$%Y!IYEA7^U)+0%B6PT4<:DSN-OS!OE QTR33Y9KN2YO\
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M -!1]JF_O_H*AHHY5V#GEW)OM4W]_P#04?:IO[_Z"H:*.5=@YY=R;[5-_?\
MT%'VJ;^_^@J&BCE78.>7<F^U3?W_ -!1]JF_O_H*AHHY5V#GEW)OM4W]_P#0
M4?:IO[_Z"H:*.5=@YY=S+GT[5I;B21/%>KPH[%EBCAM"J G[HW0$X'3DD^YI
MG]E:Q_T..M?]^;+_ .1ZUZ\YTBUL],\;-<75M!=RW<Q%MJMK-N=B[3G;+T.
M%V8!<?NUX&!A<L;I6*YY6;OL=?\ V5K'_0XZU_WYLO\ Y'J*/0M1AEEEB\5Z
MLDDS!I66VL07(  +'[/R< #GL!6Y13Y(]A>TEW,C^RM8_P"AQUK_ +\V7_R/
M1_96L?\ 0XZU_P!^;+_Y'K7HHY(]@]I+N9']E:Q_T..M?]^;+_Y'H_LK6/\
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M?4W6;SG.!$H$!#') SD#KG &:2J/H@]DNY9;PE8MJ9U#[+()RXD95N'$3N
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M4?:IO[_Z"A4FA>VB<O?^&?$?_"4Z?J$&H:?/!_:;7,A:Q820Q^3(BJ6\X;@
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MD[6'[>-[G*:EH^K3>%+3P]=:.=3N4LD2'55GC/V:Z"E?-;S"KKM.&#IN8\\
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M\S2]<_Q;L>V,\]*RK?X?-'XF@UF6_M)98+V2Z67^SQ]ID#AQY<DY<EE4. H
M4 *.#@87]?E_P1RZM?UI_F5]-\>?\4FDVKQ:G;3O8S3I>K%"/M!C&7,0R0&
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M' APTK $XS@X& 23C@ GM5?Q!K^HZ+;RWT6D13Z?;0>?<SR7@B;'=8UVMO;
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MC[5-_?\ T%0T4N5=@YY=R;[5-_?_ $%'VJ;^_P#H*AHHY5V#GEW)OM4W]_\
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M)=64IO"D5YI\%K?_ &B=H2Q6=;F2*0;LY =7#8P<8SR ,YIMUX+TN\%H)=/
M2TC$421S-&OE@@A&56 =05'RMD>U7M:UN\L=1L]-TW3H[V]N(I9RLUQY")''
MM#'=M8EB74 8QUR1BJ%]XONHM$BUVPTE;C2/L:WDL\]V(7VGG9&FUMS@=F*
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M;MT>WY5)CDP=Q/ R!FKFNZW=:=<VUCINGI?ZA<1RS+%)/Y*".,#<2VUN<LH
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MC"A7(##E X5P$S\Q=B>,D=U64O@FP2_EOHUU".>602R&/5+A5=@  642;3P
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MDES;)*86D8 L-P/09;_@-=-!I"VUS=7$4&V6Z</,V_.XA0HZGC@#I5>+P_\
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MSC@E0 ^6QFXD!SP5*GY3QR,3MK/B5HYK2ZGTR*>[TF2^MI+>WD/V<J5#(V9
M7X<88;.1TI-VO_7?_)@M;?UV_P T=Q17-Z'?7EGX M=1U6^M9IDL%G:=PT28
M\L$;R6<Y]6[]<=JQ+3QAKEQ!K,$-NM[=V<=O-%(-)N+4^7(S!CY$K;Y"H1F
M5ANZ#!JI*S:[$Q=XJ7<[^BN&N_%.J1:7874-[9M:N9A>:F-(N&CMV0X"/;B7
MS(OXMS,V%V<@9&(-6\;ZI%JFHPZ9;F>/3MB^5'I-U<F\8HLA"2Q92+(90-P;
MDY/'5#/0**XB"\\2)XE\2R0307D<%I#+;:<T+(Q=E<HH8R%5.1ACMYX^[BMK
MPMJL^JV,SW5[#/<Q2!9(TT^6S>$E0=KQRNS9YSG@$$8]:!7ZF[17EVC^);K2
M?#&@:;9*4FN_M<K3_P!GSWHC1)B,>5"0Q)+KSD <]3@5K3^+-=&CZ?>2VHTV
M)C,MY>W&EW$J1E&PK&$,DD:. S[GX4#!ZYH6JN,[NBN537M1'BU;"ZFMK2QD
M*K:EK*1Q>@Q[LI<!_+1LAOW9!;"YY!R);S5-:NO$]SI6D-I\*V5K%<3-=QO(
M9C(SA47:R[!B,Y8ANH^7CD Z6BN4;Q->C3'N?*M]ZZV-.QM;'EF<1YZ_>P>O
M3/:LJX\6>)(]%U?5XUTHQ6NI-I]M;M%)N<BY6(.[[^."> IY .?X:%JDU_6W
M^:"VMOZZ_P"3/0**X35?$^N:?J:Z,)K=KR&T%S/<PZ'=W4<A=F"((XG8Q\(<
MLS'/8=<2MXB\2:C/%%I]O9:<YTE-0E34())'CD)8>45#)Z=3@C'0YX3:6O\
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M1I9 JS*EQ(D<X7[HEC5@DF,X^8'CCI5DZ)IS?VEFW_Y"8Q=_.W[SY!'Z\?*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
HB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>cadl-20231109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-09T07:39:09.3284+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Securities Act File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cadl-20231109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-09T07:39:09.1538+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.candeltx.com/20231109" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:cadl="http://www.candeltx.com/20231109" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cadl-20231109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cadl-20231109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>cadl-20231109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-11-09T07:39:09.0935+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="cadl-20231109.xsd#DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="49.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="50.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="51.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="52.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="53.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="54.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="55.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="56.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="57.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="58.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="59.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="60.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="61.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="62.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="63.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="64.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="65.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="66.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="67.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="68.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="69.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="70.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="71.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="72.0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139744388028208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CANDEL THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001841387<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  09,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Securities Act File Number</a></td>
<td class="text">001-40629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">52-2214851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">117 Kendrick St<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Needham<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(617)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">916-5445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CADL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>cadl-20231109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cadl-20231109.xsd" xlink:type="simple"/>
    <context id="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001841387</identifier>
        </entity>
        <period>
            <startDate>2023-11-09</startDate>
            <endDate>2023-11-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_6f4ba7c2-13c9-4044-9e81-450ae118018d">0001841387</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_9ae41750-cb44-4764-8257-40ab0b04a20c">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_4b1d8c76-935e-47aa-9d00-8f3bed627dda">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_515ef461-7976-4590-a038-e0fbe30acf34">2023-11-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_302b2f5f-2bc2-4f67-ab37-886093df44ad">CANDEL THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_b876a9f3-dc67-47aa-8c58-db21b4cf85c4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_802c36a0-97f0-4dbc-8a59-ae26d960845d">001-40629</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_7011e4da-9101-4675-a799-fef2726805c0">52-2214851</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_eb66fc36-a6fc-4657-90c6-81bb0b96ae30">117 Kendrick St</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_5654517e-c17a-401b-86de-258da7a09d5c">Suite 450</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_80b0f7b3-0cc3-4003-a0fe-7119c916fa74">Needham</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_b282b600-a617-4d0b-80b3-a564e2038431">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_f75d89b3-5110-4ced-a088-87d1f862142d">02494</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_d411c8fb-0607-4a67-bb96-b16c88f29e92">(617)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_3cbbff09-b5c3-43b4-863b-6d23bdc797d6">916-5445</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_692c1c70-6de6-4d63-8a5b-1ff6b13d6457">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_cb75ba76-dc7e-4f94-a527-e8d09504879f">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_efca5ff6-a792-4e69-adbb-a22bacf60d7f">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_ea5ea731-ed99-4f65-8f14-fdc2bf65b99e">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_b89d3587-ab9a-4b36-840f-7981445483d3">Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_861190f3-18ee-492b-b2ee-06bfd38ba7f8">CADL</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_aa011151-d2ee-4e78-9031-a5951ed2a3fc">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_5410f520-43d1-49bb-9827-46cc817306bd">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2"
      id="F_3699c6e7-1005-412e-b553-3e63a45bef8c">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M=>Y!L/?P&HT=S8\?M_P!4$L#!!0    (  %":5<D'INBK0   /@!   :
M>&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=
M6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\
MI%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X
M\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].
MM.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  !0FE799!YDAD!  #/ P
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M<' N>&UL4$L! A0#%     @  4)I5WI+#VKO    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @  4)I5YE<G",0
M!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    "  !0FE7?'IX:H@$  #/$0  &               @($."
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @  4)I5Y^@&_"Q
M @  X@P   T              ( !S P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M    "  !0FE7EXJ[',     3 @  "P              @ &H#P  7W)E;',O
M+G)E;'-02P$"% ,4    "  !0FE7'#AEZC\!   \ @  #P
M@ &1$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @  4)I5R0>FZ*M
M^ $  !H              ( !_1$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR
M96QS4$L! A0#%     @  4)I5V60>9(9 0  SP,  !,              ( !
MXA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  +!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="cadl-20231109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="cadl-20231109.htm">cadl-20231109.htm</File>
    <File>cadl-20231109.xsd</File>
    <File>cadl-20231109_lab.xml</File>
    <File>cadl-20231109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "cadl-20231109.htm": {
   "nsprefix": "cadl",
   "nsuri": "http://www.candeltx.com/20231109",
   "dts": {
    "inline": {
     "local": [
      "cadl-20231109.htm"
     ]
    },
    "schema": {
     "local": [
      "cadl-20231109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "cadl-20231109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cadl-20231109_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 25,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 24
   },
   "report": {
    "R1": {
     "role": "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cadl-20231109.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_f6a25d2b-c89d-45c0-9d3c-926d4f1128e2",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "cadl-20231109.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation State Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities Act File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security 12b Title",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.candeltx.com/20231109/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950170-23-061558-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-061558-xbrl.zip
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MZ#E)9!Q/T<<H80F/6(SZLR[W8(R\A0[C&)VKMW)T+G.974G14DW^=# H !8
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M+G?.G<D91T8%J\7+_1[2.NG6"<.4NE5-'NUJ)^AM="MI[Y>KGU!+ P04
M"  !0FE7YC'KSBH&  !^.0  %0   &-A9&PM,C R,S$Q,#E?;&%B+GAM;-5;
M;6_B.!#^WE\QQWUI=1M"X*0[4-L51]L5NKZIL+K5G4ZKD!BP-L3(#@7^_=EY
M*R9.H% GW*>FR>3Q,Q-[/'XZO?R\FGGPBBC#Q+^J6?5&#9#O$!?[DZO:UX'1
M'?3Z_=KGZ[/+GPP#;N[ZC_"(EM!U OR*;C!S/,(6%,'YX.$"OOWQ<@_WV/\Q
MLAF"&^(L9L@/P(!I$,P[IKE<+NON&/N,>(N #\CJ#IF98!@Q?(\B6]R'&SM
MT&DVFBW#LHQ&>]CXK=-J=QKM>JOY^Z^_-!J=1F/C-3)?4SR9!G#N7(!XBX_M
M^\CSUG"'?=MWL.W!(!GT$_1]IPY=SX,7\1:#%\00?45N/<+TN <=+W%CQ7"'
M.5,TL^^)$]*[JFWXLQI1KT[HQ&PV&BTS?2O70OQF)&:&N&583:-EU5?,K0'_
M&CX+Q]YCD,1\E;%?MD)KJ]UNF^'3U)1AE2&'M<QO#_>#T$^#?Z& 1PW5KL\
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MKY'*T$*P&DQF8W_'(%J>'NG7K4SMM=MM)[OZ))7$)(1N/>?KW7"<S=.&%4J
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MTDOG" <DTM^NSG87U!_U7Z]7_P!02P,$%     @  4)I5XXO\#-A'   B?X
M  \   !C861L+65X.3E?,2YH=&WM/6ESVSBRW_=7X&4GNW:5I$CRD?B8U'-L
M3Y*J)..)LS/OVQ9$@A(2DN  I&3-KW_=#?#094OC2[(Y'S*R1 +H1M]H=!\/
MTBA\^P]V/!#<A_^SXU2FH7A[_G_-@X-6Y_B5_1,>>.6>..XI?\Q,.@[%SR\B
MKOLR/F0\2]7_R"A1.N5Q>I1PWY=Q_Y"]2:Z.7M"P2?Y**J[2IHQ]$:>'[:-
MQ6G3R+_$8:>=I$=VO&:JDORW@$<R'!]^DY$P[(L8L:\JXG'^8$^EJ8K@61J5
MA[(?'VK9'Z0PZS&^G\\Z&LA4-$W"/7&8:-$<:9Y4)^_ Y-7Y_GT*@_6T_'?#
M\-@TC= R.(I@QI'TT\%A(-.F!X\#$##3O_[9V6\?';_" =X>OTK6 6!/A4H?
M_K--_QTM!G\D\.W#6.F(A]75=9?!B'T>9SR4*?SN+<31^=5 ]F3*+%4]$J9"
M$1"B9-1G1GL_OX /L'6[^^TW^SO_;;>^)_T7C(?I_!]R4B+HNMTNT/; 8N_
MTGE.!X\%UBH$OSNUO3/3K2>MUZ#6H-:@;BZH*ZJEG@K]ZS!QHB5HK47PGW*
M+F3?!@+&%5DJ/<.^"C12#'PIM<]^R[A.A6;==G>'_2)C'GLP(#QDLA >@O?A
MLP>CL5.EX46>"O8!5A;BZLQ:8795(KH>=7-)QY?#2<.OB0LYW&GM[.R\/)J$
MVI<F"?GX, C%U23,WS.3RF"<3T9/@ T!&W%$T#4!CL@<]K@1H8S%%![>( J+
M15>GOC.BF[6%IJW#Y1AP/D)DC% U"2\K3'$-UJKHV-U]?= YZ.SN==K[.P>O
M7])67@%Y=XO-K.RB?:O3;K^<6MZ]8]!2W_+FX\=8ILB9)M-#.80//D\Y"[2*
M6#( 2F%=YL'"I0<_I3@V4P$[/?G2[.ZV#YB,&?>'P-S"9[&*FP96%S)/P#]A
M%O>9AS]IMO7E\O33Z38S S6")XNY3):@T)!#@:/R&,;SM(!9?99R"5/%+!T(
M%O$TT^#VE"]Z\$$43 2(=__>%3/M U9K=JK9Z6^STZI<U%/:%QI!8EH8X:6\
M%PJ6<.('T*\Y)_DB4K%)45_ZR# "L!W1'P5OD"Z%X5]W6KLO&4_9SCZ#E]*!
MP8D2& V6:F 9@MX;R70 T\,_Q7I0.\.6Q3X'30XC>5P+MG6I@(.] 2Q <U_"
M,,"=0Z%-9EAGO_7Z)8Z.W(K(T"ID7$>,!V@$+#56S<TU-Z\;-Y\A%R=9+Y1F
M *P"!/X%59&89$/BI AM6>(E9*.=3J?-8L%U.&:^@@'@,7&5 %_#AT@ R<=,
M ?.@MBP8M\J=-)(6H.<T#CP  )M]X!7!^J&$K6%;']Z_WSYB,HJR&-#4)]'B
M#7C<%R;GQ#0#_F*1]+02\5!J%=,JD;W!<D_@02.C!+:4P8^9:7:8$5HERH ,
M&\ITS$8"8.7&*##>"UD!KVA8>REQ:LZM.7?=./<2]E8&P!2P)EBJA\PV!J;0
M*NL/B#EB^"ID(O[T\?V';^=?P"_;VSDZ*QZ]"'D:P+(F61T^@J9$KW?,N.>X
M!+3:20AJOMEM=YH1!V[K-&B*0&J3$M]KB9P'' J,AIQ.7%L,U$>N] 6L1R4P
M26;0UL4!IE97VMH\YN$8W>X&F> ,L%K8%Y%"WQP6U4-3.LTMAWP[[W6;5HKN
M'_?TV_5;U92#/BG3[C42@:+J?J,\TT</UX<JOIR?GWTX^=Q@GT$%M!KL"W!&
MU -2.FC8N,[6^T^_OCMG7\[_N/SCX]?S;4:BH[-[=#_$MMKJY\2H&NQC[+78
MEOL)=",RV:F*P,X>;]_!FF^'[W7 VM87;GS^YR%8,6>?MAL@6@JY LJC+UA/
M*A!U,(E'.$6CP^*/!<K+T','M\#),A1CLP)/ @ND"BR0,"GMG0!7[T05"$_E
M\S&8/Q@<@!&#(GZH7?PP<'N74K#Q3Q=L%+"M/KL426KI=*=M";5!)@]:+1(?
M )B*F&.6@*<F6@\9<+Q[-K_MIENV]8X<7X##RB(T-4D1FHHF!13V80N<>:HR
M/5>?)4YUVC"OBA&:_KB9TT<B$S+4&G9:_X@9+GUVP;.070C<QV_\!PB=LP:[
M&, _OWP6_J4GX2^86OJY!7LZD")@YU=@(U, Z=< %@DOHV--<+18#M<?8,1J
MU*8>+!F(V&>],9&/MB'H@L1QW!Z:U_H'^MKDPP.E51UUBF19>IIVSBV9%>8_
M/%P:\&"MMU 6(:V&SFC %1@/Z-\3; 0XMZL!CP%L:NF3O0'K= Z(9QUN&/0!
MI<3R]I;UBUIK(,'8KQD20= $]#;!;0L#0-H0XR1]0B%:2." >4"!ALC"%TCB
MZ,<I!H3IR11> (4O?=RJOX3?8&9L0*3 1@,3R*9UJXCF*5J3@'THB-A1<B'9
MB 8P$= DQCMCY)I(&D&D!'QOI53A]?7$6*%#)DVJ-%$A"B;053Q4(#^)TS@#
M$Y&\11"S? BB"Z-#A@<"* F)+E4A_-R32%KKL =3\G2@\X4DP'Y--$Q_-"DV
M=,C#$1^;.I?E62@:X(1 AJ+%0"*K'N +PP@D;7V@[#+X[WB+SA%D#*^@^^7$
MG]4U>'* F@@E/_&C538%H[H1R$>SK]I0Y(0S-A6XF0V"YK*\E:NJY[U]%7T:
M*O4#!=H(P[H@]"(PRV0"0@DEI"<3TEZD0 ''OLI2"DJ!,;:+'JL79C[YN"JA
MD/=,**P,GZ.27"Z$;C4S?/BMZR;*A\_-%B"#9J"%6#2/ACT'4?T7&BEN2I-F
M_GABIJ%I6;*RPP@9AJC]25P+G-Y&_4+E6>V!LX/I#+9FU4K(E^:#8H"95EO6
MS@V8D+!AFJ*,,"N:VK#[3$OS8_&J"&^[Q08QS#,DMH'7RU &K0N^+'9;QM^%
MA\^9? US39\\(&F$1[J.@U*&YVFVP@H\TRVT_/#\ .E#^!MNE=_.&9R31O$O
M'B5'>=K$PF2)=<@E(%@?/.HZC>![B+K>-,6&1UU7(]$+%*L\8O\A']H<KG8.
MT&DO2XVTK T\!=@<>GS=WJG^MX\$J=:0$I?W1PMU:-7+SA'[ LK_DM)33M&L
M_(3I*:<3Z2DKTN]^:W__]9/.SMH< CXX.-CO[!T<O-D%>7JPFPO4/<XW2:#.
M)H]4K5]KWTY9?B;K]X5)K4$723HYHA@#&KMH8TV;U@VTKXPT:>'VK)IV-7E.
M/5"FL&(+0QMM?V$20!<%M>001Z'8R<79UJ?M3L7SVCI5 Z53UMUNU?Q7\]^C
M\A^E>[@<Q8.=E\@^DPD9%)$KN&$+0>SN[QUUNB[!:MMF3(1JA(=+L<"(X] &
M_B[.FD3YXBIQKF@#F$=Z@SP)TEAF5[B6:9\.G#!8)7!R6BXHBUWHD4(@JHB9
M#(3W(U'@ @*?TLT@/"HIV V^5P1&$UU$!XO2IF:^FOD>E_F^JAZ 6XW8N2,2
M1]@VM$?!DZFD)Z6U"+F-0O1$.A(B#\)4\J%^B#$302"\M(S=)RK)\A=M>+#D
MN()C**Q8)BSGZG:268&I,M!_=M:>+-96!+^XP1P-7^+T%"LI]'A^@+ J!SZD
M^U3[\\_1?Z)07A,#3GDD#[,0WU,6XOM*%F*M.C:6<)^&ZG!)N66B;I$F,NE#
M=2HGP4HW2>XJD,H+PNEY*'NWLS O%X_U:_*OR?]QR1_ #C!E(>Z;J<ST 4\M
M_5-:-[KE&>4_H&$D331!Z7C2HR78-]H9-C9U9VRD*:VNB2/5B(.Q ^Y-IC'U
MAXEX8+-3W6D/.CJ4W()^%  NKB3LBHL$])3O$L$^7/[.MN;EHV\W.ZW/"W+E
MMZ)?+[=QX,YN*_>^*(FF.%;.%S'!N3,S-SMV+K:UO_]RN^'6G#(A"21 7\Y9
MZ-&5.;JEN6AQEYN+BZ1!G0&QVM776DS68O*.Q>2)R3U*BJ]Z6=I4 9U#GR1:
MAJQ;9(O2[RXL4UQIDW$F)A.MZ,XJPY!K]23\^H-PDD*Q8CY(XV8H(YG:/(@K
MS#NSN5R%!*O>'\*GW.K+>T2_7N($>^U2R&V=Z(B=T##OMENL-DUJGGM4GL.,
MUXI&MJ<,2+2P=J%-)1'V6Y.RO?"X(,$0C1:)T*F2RUQ <]IXEA<;><#&6%.H
MX$N/#CW\#/-V6$\K[A//V%6)Z=Q.QOM<@E'E# 9\,O^&;A*)48C9ZJ$[0J'T
M4+0T^B(V-1/63/C8B@]TPFDC5VAE]OL[-$+9-W<GSIV%_Z*RV.>6><#P=[H+
MZ%L HV4\+:ZF42R55"JR*C 7J#2GI0HVV\H2M+.-O)K(% ,F8P'>'G"G)BOS
MR-*QSS=UYD@=^;QMYLA%>='#,DDMT3>67I^&1+^P5_3G)$[/'H]-W6>B VH7
MY< XAC5A+L' PKLD>%+]<>(RE[U.15E2EQ^_G6ZSDSC&&-)G(4@7X!O6:^IQ
M=_N/NPQD&=E[RAA <E:>BOL*WFI4<IH;RZ1W)V&&!VC*UQEZ2WU!T1FR!B_5
MZ715DD"%(1WB]\:NFHK]5B\HLX*5BR*1<DR(!B:O7.P""Q$O"G"@4>5Q[<F8
M3CTNSDX $[P ZR3KX]EEM^,NQN8.)OJ7D_<+:XE12XQ'L0%7+14T'4NM9GRY
MI"[XH8M1T9TYUP"(:[7HXU6;FQDVT1*S5!2NK"_TN)$7%E(Q6)ZVNM"<Y4\N
M>,FQ:UZL>?&1M?=D\J2[@%/)G70I:*!'>0AZ%(]M7((E7F#&>(0MJ\7#(5[)
M)X+/]?5DA.3TI'/0/& AGEL8ME7: JBX*$[1RT CQMONJC9IYX+!6NQ2 CQ<
M5VZYDOT YL',04NE[%?-8C6+/2Z+O2L(O;! )PY& :44U@..Z^/=%>2'RJ53
M%RZ4[B(:.SU[PY+<YNZ#[?K7.!+L7?F=-TX5!?'9-SM  Z?PM:3J /8+"LJ[
MX8%GT(9DJ30F$Z61BCHWY3*>.&&<3$C+TT8!V$#B+;^IE#G.M,NDBU-)/)X7
M:!#WGVMV6^;<KYGS>45;IBM<S2G 52N3C:77IZ%,+HIHR8*B;K: 6Y%L=C--
M-^84C//M71L,LF"E&-!8,:#;#DT9.#-E3.;5WK%ZRTP4-:%@3(!V&QF'5//J
M;/?U*YCKZP7LQTZO<X3^W6#$[0FT4RAXD!;3_UP&=N6Z>ZLHY7YS?;PZ):9.
MB;E/R3:41MJ,C,.!] $OZR+K-DC&V9 I"B J$<&X#T]*4ZF[LDR1R;6H_U3;
M"[6]\+BQ5E<[!=BDRC)T*#!Q\H*ZON+'412%)Y7LLGG6Q$E> _8DKP$+BEG:
M0B_NBA%3"<9*0ZH:!II]'&*"BZ>BGHS==2=X&.NS6Q-B2+>B3,-:#R*F0Q%*
ME",K@O)WBZM.E6%86FT  T.BE0._YY6GL5X?UG[W  J3"*S@2&6>G+0PQ0/I
MTA<8%WFN&]U\9]50?EEAZ;,,P214L;B/*C ;6GQ[<\3=TR@#<T[YJ,C!MF#K
M#56]7'&!90]]X3WNC;U0@:ARLB?/ RRS<O/+U8#AOCV6)K_)+%.JP"PN5="<
MJE5@[X!S1"?5PK45&<H*!I7B8RM&V)Y^IZ>:*]>$*Z^I..=8,\A038M8@T]
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M&Q6P7^W9##SP]- U+3^N1]<6G0JK#&2+#Q0DKK ]"C,#KFVR5H)U0.U?D<H
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M+3(P,C,Q,3 Y+FAT;5!+ 0(4 Q0    (  %":5>:OLAA"P,  )\)   1
M          "  <43  !C861L+3(P,C,Q,3 Y+GAS9%!+ 0(4 Q0    (  %"
M:5?F,>O.*@8  'XY   5              "  ?\6  !C861L+3(P,C,Q,3 Y
M7VQA8BYX;6Q02P$"% ,4    "  !0FE7'F*KK\P$  "T+   %0
M    @ %<'0  8V%D;"TR,#(S,3$P.5]P<F4N>&UL4$L! A0#%     @  4)I
M5XXO\#-A'   B?X   \              ( !6R(  &-A9&PM97@Y.5\Q+FAT
7;5!+!08     !0 % $$!  #I/@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
